๐ค Bรกez-Santos, Yahira M.
Keywords
Articles (6)
-
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases
๐ค Bรกez-Santos, Yahira M. ๐ค Barraza, Scott J. ๐ค Wilson, Michael W. ๐ค Agius, Michael P. ๐ค Mielech, Anna M. ๐ค Davis, Nicole M. ๐ค Baker, Susan C. ๐ค Larsen, Scott D. ๐ค Mesecar, Andrew D. โฐ 2014 ๐ Journal of Medicinal Chemistry
-
Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the middle east respiratory syndrome coronavirus
๐ค Bรกez-Santos, Yahira M. ๐ค Mielech, Anna M. ๐ค Deng, Xufang ๐ค Baker, Susan ๐ค Mesecar, Andrew D. โฐ 2014 ๐ Journal of Virology
-
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
๐ค Bรกez-Santos, Yahira M. ๐ค St. John, Sarah E. ๐ค Mesecar, Andrew D. โฐ 2015 ๐ Antiviral Research
-
Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases
๐ค Clementz, Mark A. ๐ค Chen, Zhongbin ๐ค Banach, Bridget S. ๐ค Wang, Yanhua ๐ค Sun, Li ๐ค Ratia, Kiira ๐ค Baez-Santos, Yahira M. ๐ค Wang, Jie ๐ค Takayama, Jun ๐ค Ghosh, Arun K. ๐ค Li, Kui ๐ค Mesecar, Andrew D. ๐ค Baker, Susan C. โฐ 2010 ๐ Journal of Virology
-
Discovery, synthesis, and structure-based optimization of a series of N -(tert -Butyl)-2-(N -arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease
๐ค Jacobs, Jon ๐ค Grum-Tokars, Valerie ๐ค Zhou, Ya ๐ค Turlington, Mark ๐ค Saldanha, S. Adrian ๐ค Chase, Peter ๐ค Eggler, Aimee ๐ค Dawson, Eric S. ๐ค Baez-Santos, Yahira M. ๐ค Tomar, Sakshi ๐ค Mielech, Anna M. ๐ค Baker, Susan C. ๐ค Lindsley, Craig W. ๐ค Hodder, Peter ๐ค Mesecar, Andrew ๐ค Stauffer, Shaun R. โฐ 2013 ๐ Journal of Medicinal Chemistry
-
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
๐ค Turlington, Mark ๐ค Chun, Aspen ๐ค Tomar, Sakshi ๐ค Eggler, Aimee ๐ค Grum-Tokars, Valerie ๐ค Jacobs, Jon ๐ค Daniels, J. Scott ๐ค Dawson, Eric ๐ค Saldanha, Adrian ๐ค Chase, Peter ๐ค Baez-Santos, Yahira M. ๐ค Lindsley, Craig W. ๐ค Hodder, Peter ๐ค Mesecar, Andrew D. ๐ค Stauffer, Shaun R. โฐ 2013 ๐ Bioorganic and Medicinal Chemistry Letters